Collegium Pharmaceutical (COLL)
(Real Time Quote from BATS)
$37.15 USD
+1.53 (4.30%)
Updated Aug 13, 2024 03:08 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | 1.54 |
EPS Last Quarter | 1.62 |
Last EPS Surprise | 3.85% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 6.30 |
Next Year | 6.87 |
EPS (TTM) | 5.99 |
P/E (F1) | 5.65 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 154.92M | 180.99M | 627.97M | 735.04M |
# of Estimates | 5 | 4 | 4 | 4 |
High Estimate | 174.70M | 185.65M | 641.50M | 762.62M |
Low Estimate | 143.48M | 176.60M | 617.99M | 706.44M |
Year ago Sales | 136.71M | 149.75M | 566.77M | 627.97M |
Year over Year Growth Est. | 13.32% | 20.86% | 10.80% | 17.05% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.54 | 1.75 | 6.30 | 6.87 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | 1.49 | 1.69 | 6.16 | 6.43 |
High Estimate | 1.58 | 1.95 | 6.49 | 7.29 |
Low Estimate | 1.49 | 1.62 | 6.16 | 6.43 |
Year ago EPS | 1.34 | 1.58 | 5.47 | 6.30 |
Year over Year Growth Est. | 14.93% | 10.76% | 15.17% | 9.05% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 2 | 2 | 2 |
Up Last 60 Days | 0 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 0 | 1 | 1 |
Down Last 60 Days | 3 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.54 | 1.75 | 6.30 | 6.87 |
7 Days Ago | 1.54 | 1.75 | 6.30 | 6.87 |
30 Days Ago | 1.59 | 1.72 | 6.28 | 6.87 |
60 Days Ago | 1.59 | 1.72 | 6.28 | 6.87 |
90 Days Ago | 1.59 | 1.72 | 6.28 | 6.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.54 | 1.75 | 6.30 | 6.87 |
Zacks Consensus Estimate | 1.54 | 1.75 | 6.30 | 6.87 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.62 | 1.45 | 1.58 | 1.34 | NA |
Estimate | 1.56 | 1.49 | 1.33 | 1.24 | NA |
Difference | 0.06 | -0.04 | 0.25 | 0.10 | 0.09 |
Surprise | 3.85% | -2.68% | 18.80% | 8.06% | 7.01% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more